Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Canntab Therapeutics says receiving medical sales license from Health Canada in 'pivotal moment'

Canntab Therapeutics says receiving medical sales license from Health Canada in 'pivotal moment'

Canntab Therapeutics Limited CEO Larry Latowski and CFO Richard Goldstein tell Proactive it has received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers.

The final regulatory step was required to launch the company's direct-to-consumer website, allowing patients across Canada to order online the unique patented exact-dosage hard tablets and caplets of THC and CBD in various strengths.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK